NFE2L2 and melanoma: Mouse allograft and patient derived xenograft studies in melanoma and NSCLC demonstrate that NRF2 activity promotes PD-L1 expression and diminishes the infiltration of lymphocytes into the tumor microenvironment [71, 72].